TEVA PHARMA secures contract for Antineoplastic agents - Supply of parenteral cytostatic drugs with active ingredients cabazitaxel, arsenic trioxide, paclitaxel, paclitaxel-albumin, bendamustine, bortezomib, busulfan, carboplatin, cisplatin, doxorubicin, etoposide, fludarabine, gemcitabine, irinotecan, vinorelbine and cyclophosphamide

Spain, Dec. 12 -- Spain based TEVA PHARMA has secured contract from Servicio Murciano de Salud - Junta de Compras for Antineoplastic agents - Supply of parenteral cytostatic drugs with active ingredients cabazitaxel, arsenic trioxide, paclitaxel, paclitaxel-albumin, bendamustine, bortezomib, busulfan, carboplatin, cisplatin, doxorubicin, etoposide, fludarabine, gemcitabine, irinotecan, vinorelbine and cyclophosphamide. The value of the contract is worth 2326600 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....